Ownership and insider activity for Bioventus Inc. (BVS): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimula...
Price
| Price | $13.20 |
| Market Cap | $894M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-06-02 | Bartholdson John A. | M-Exempt | 32,282 | |
| 2026-06-03 | Bartholdson John A. | A-Award | 25,146 | |
| 2026-06-02 | Bartholdson John A. | M-Exempt | 32,282 | |
| 2026-06-02 | SUTTER MARTIN P | M-Exempt | 32,282 | |
| 2026-06-03 | SUTTER MARTIN P | A-Award | 25,146 | |
| 2026-06-02 | SUTTER MARTIN P | M-Exempt | 32,282 | |
| 2026-06-02 | STALNECKER SUSAN M | M-Exempt | 32,282 | |
| 2026-06-03 | STALNECKER SUSAN M | A-Award | 25,146 | |
| 2026-06-02 | STALNECKER SUSAN M | M-Exempt | 32,282 | |
| 2026-06-02 | NOHRA GUY P | M-Exempt | 32,282 |
Balance Sheet (10y)
| Year | 2014 | 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15.8M | $5.0M | $42.8M | $64.5M | $86.8M | $43.9M | $30.2M | $37.0M | $41.6M | $51.2M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $47.1M | $54.5M | $73.0M | $85.1M | $88.3M | $125.0M | $136.3M | $122.8M | $127.4M | $128.3M |
| Inventory | $26.7M | $35.2M | $27.4M | $27.3M | $29.1M | $61.7M | $84.8M | $91.3M | $92.5M | $82.2M |
| Total Current Assets | $95.2M | $99.4M | $148.4M | $183.0M | $211.8M | $263.1M | $272.6M | $268.0M | $275.6M | $272.8M |
| Property, Plant & Equipment | $10.4M | $9.6M | $4.8M | $19.8M | $21.8M | $40.2M | $44.1M | $50.0M | $33.5M | $27.0M |
| Goodwill | $50.0M | $58.7M | $49.8M | $49.8M | $49.8M | $147.6M | $7.5M | $7.5M | $7.5M | $7.5M |
| Intangible Assets | $274.3M | $319.2M | $237.0M | $216.5M | $191.7M | $695.2M | $639.9M | $482.4M | $404.7M | $368.4M |
| Total Assets | $430.4M | $487.4M | $442.7M | $472.4M | $494.5M | $1.23B | $1.37B | $810.9M | $728.0M | $683.6M |
| Accounts Payable | $5.4M | $8.4M | $8.2M | $6.4M | $4.4M | $16.9M | $36.7M | $23.0M | $23.7M | $10.9M |
| Short-term Debt | $7.2M | $36.5M | $5.2M | $10.0M | $15.0M | $18.0M | $33.1M | $27.8M | $27.3M | $19.2M |
| Total Current Liabilities | $52.2M | $87.7M | $65.4M | $89.0M | $122.6M | $180.9M | $304.0M | $175.5M | $210.4M | $160.4M |
| Long-term Debt | $162.3M | $157.6M | $189.6M | $188.0M | $173.4M | $339.6M | $385.0M | $367.0M | $308.3M | $279.0M |
| Total Liabilities | $252.9M | $295.0M | $297.5M | $326.8M | $350.3M | $692.1M | $960.4M | $589.8M | $542.4M | $455.1M |
| Retained Earnings | -$56.5M | -$91.8M | -$139.8M | -$141.7M | -$144.5M | -$6.6M | -$165.3M | -$321.5M | -$355.1M | -$334.9M |
| Total Equity | $177.5M | $192.3M | $145.3M | $143.0M | $142.2M | $458.9M | $325.2M | $173.6M | $147.9M | $184.1M |
| Total Debt | $171.0M | $196.5M | $194.8M | $198.0M | $188.4M | $357.7M | $418.1M | $394.8M | $335.6M | $311.3M |
| Net Debt | $155.2M | $191.6M | $152.1M | $133.4M | $101.5M | $313.7M | $387.9M | $357.9M | $294.0M | $260.1M |
| Working Capital | $43.1M | $11.7M | $82.9M | $94.0M | $89.2M | $82.2M | -$31.4M | $92.5M | $65.2M | $112.5M |
Financial Health
| Debt / Equity | 1.16 |
| Current Ratio | 1.69 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 1.28 |
Profitability
| Return on Equity | 28.39% |
| Return on Invested Capital | 11.37% |
| Return on Assets | 8.09% |
| Gross Margin | 68.00% |
| Operating Margin | 10.63% |
| Net Margin | 9.36% |
Related companies: AVNS · BFLY · CBLL · CTKB · KIDS · LAB · SMLR
Explore sector: Healthcare · Medical - Devices
More sections of BVS: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks